Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 704-709

  Fiebich, Bernd L ^a   Hüll, Michael ^a   Lieb, Klaus ^a   Gyufko, Karin ^a   Berger, Mathias ^a   Bauer, Joachim ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Cyclooxygenase; Interleukin 1; Interleukin 6 Gene expression; Nonsteroidal antiinflammatory drugs; Prostaglandin E2

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; INTERLEUKIN 1; OXYTOCIC AGENT; VASODILATOR AGENT;

ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; ASTROCYTOMA; BIOSYNTHESIS; BRAIN; CELL CULTURE; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; KINETICS; METABOLISM;

ALPROSTADIL; ASTROCYTOMA; BRAIN; DINOPROST; DINOPROSTONE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; OXYTOCICS; PROSTAGLANDIN D2; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASODILATOR AGENTS;

EID: 0030614598     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020704.x     Document Type: Article

References (43)

1. 2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J. Rheumatol 23, 862-868.
2. Aisen P. S. and Davis K. L. (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiatry 151, 1105-1133.
3. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., and Berger M. (1991) Interleukin-6 and alpha2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
4. Benveniste E. N. (1994) Cytokine circuits in brain. Implications for AIDS dementia complex. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 72, 71-88.
5. Betmouni S., Perry V. H., and Gordon J. L. (1996) Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74, 1-5.
6. Breder C. D., Dewitt D., and Kraig R. P. (1995) Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355, 296-315.
7. Breitner J. C. S. (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47, 401-411.
8. Breitner J. C. S., Welsh K. A., Helms M. J., Gaskell P. C., Gau B. A., Roses A. D., Pericak-Vance M. A., and Saunders A. M. (1995) Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523-530.
9. Brown D. R., Schmidt B., and Kretzschmar H. A. (1996) Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380, 345-347.
10. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B., and Mucke L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061-10065.
11. Cao C. Y., Matsumura K., Yamagata K., and Watanabe Y. (1995) Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res. 697, 187-196.
12. Chen S. T., Hsu C. Y., Hogan E. L., Halushka P. V., Linet O. I., and Yatsu F. M. (1986) Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology 36, 466-470.
13. Chiang C. S., Stalder A., Samimi A., and Campbell I. L. (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16, 212-221.
14. Das S. and Potter H. (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14, 447-456.
15. Dendorfer U., Oettgen P., and Libermann T. A. (1994) Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP. and lipopolysaccharide. Mol. Cell. Biol 14, 4443-4454.
16. Epstein L. G. and Gendelman H. E. (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33, 429-436.
17. 2a-receptors. Glia (in press).
18. 2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J. Neurochem. 66, 1426-1431.
19. Fretland D. J. (1992) Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis. Prostaglandins Leukot. Essent. Fatty Acids 45, 249-257.
20. Fujimoto N., Kaneko T., Eguchi N., Urade Y., Mizuno N., and Hayaishi O. (1992) Biochemical and immunohistochemical demonstration of a tightly bound form of prostaglandin E2 in the rat brain. Neuroscience 49, 591-606.
21. Griffin D. E., Wesselingh S. L., and McArthur J. C. (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35, 592-597.
22. Griffin W. S. T., Sheng J. G., Roberts G. W., and Mrak R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276-281.
23. Hartung H. P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J. J., and Toyka K. V. (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40, 197-210.
24. 2. FASEB J. 5, 25-75.
25. 2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. USA 93, 4885-4890.
26. Horiguchi S., Ueno R., Hyodo M., and Hayaishi O. (1986) Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F2 to conscious mice. Eur. J. Pharmacol. 122, 173-179.
27. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 89, 544-551.
28. Lieb K., Kaltschmidt C., Kaltschmidt K., Baeuerle P. A., Berger M., Bauer J., and Fiebich B. L. (1996a) Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor α genes in the human astrocytoma cell line U373. J. Neurochem. 66, 1496-1503.
29. 1-antichymotrypsin expression in human astrocytoma cells by activation of nuclear factor-κB. J. Neurochem. 67, 2039-2044.
30. Merrill J. E. (1992) Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12, 167-170.
31. Minghetti L. and Levi G. (1995) Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65, 2690-2698.
32. Minghetti L., Polazzi E., Nicolini A., Créminon C., and Levi G. (1996) Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J. Neurochem. 66, 1963-1970.
33. Molina-Holgado F., Lledó A., and Guaza C. (1995) Evidence for cyclooxygenase activation by nitric oxide in astrocytes. Glia 15, 167-172.
34. Pairet M. and Engelhardt G. (1996) Distinct isoforms (COX-1 and COX-2 ) of cyclooxygenase: possible physiological and therapeutic implications. Fundam. Clin. Pharmacol 10, 1-15.
35. Rogers J., Kirby L. C., Hempelman S. R., Berry D. L., McGeer P. L., Kaszniak A. W., Zalinski J., Cofield M., Mansukhani L., and Wilson P. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611.
36. Schettini G., Grimaldi M., Navarra P., Pozzoli G., Reichlin S., and Preziosi P. (1994) Regulation of interleukin 6 production by cAMP-protein kinase-A pathway in rat cortical astrocytes. Pharmacol. Res. 30, 13-24.
37. Slepko N. and Levi G. (1996) Progressive activation of adult microglial cells in vitro. Glia 16, 241-246.
38. 1 within the hypothalamus of the rat. J. Physiol (Lond.) 432, 99-110.
39. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., and Griffin D.E. (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360.
40. Williams A. E., Van Dam A. M., Man-A-Hing W. K., Berkenbosch F., Eikelenboom P., and Fraser H. (1994) Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 654, 200-206.
41. Wood J. A., Wood P. L., Ryan R., Graff Radford N. R., Pilapil C., Robitaille Y., and Quirion R. (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
42. Woodroofe M. N. and Cuzner M. L. (1993) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5, 583-588.
43. Yamagata K., Andreasson K. I., Kaufmann W. E., Barnes C. A., and Worley P. F. (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11, 371-386.